Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05289557 · ClinicalTrials.gov registry record · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
A Phase 3 study of Morning Sickness, sponsored by Duchesnay.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 274
- Enrollment target
- 10
- Study locations
NCT05289557 is a Phase 3 study of Morning Sickness that is actively recruiting participants, run by Duchesnay. The registered enrollment target is 274 participants. The trial reports 10 study locations across 6 states.
The verdict
NCT05289557, a Phase 3 study of Morning Sickness, is actively recruiting participants, sponsored by Duchesnay.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 274 participants
- Enrollment target
- 10
- Study locations
Study Summary
The primary objective of this study is to compare the efficacy of Bonjesta for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Bonjesta in pregnant adolescents aged 12 to 17 years with placebo.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Bonjesta
Study Locations (10)
Florida
- Vital Pharma Research - Hialeah
- New Horizon Research Center - Miami
- Emerald Coast OB/GYN Clinical Research - Panama City
Texas
- Maximos OBGYN - League City
- Axon Clinical Research - Mesquite
- Advances in Health - Pearland
California
- Velvet Clinical Research - Burbank
Idaho
- Clinical Research Prime - Idaho Falls
North Carolina
- Unified Women's Clinical Research - Winston-Salem
South Carolina
- Clinovacare Medical Research Center - West Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2027-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05289557
The ClinicalTrials.gov registry entry for NCT05289557 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 274 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duchesnay, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Morning Sickness appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05289557 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Florida, Texas, California.
Frequently Asked Questions
What is clinical trial NCT05289557 about?
NCT05289557 is a clinical study titled "The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents". The primary objective of this study is to compare the efficacy of Bonjesta for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Bonjesta in pregnant adolescents aged 12...
What is the current status of trial NCT05289557?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 274 participants. The study started on 2022-05-01. Estimated completion is 2027-12.
What conditions does trial NCT05289557 study?
This clinical trial studies the following conditions: Morning Sickness.
What interventions are being tested in trial NCT05289557?
The interventions under investigation include: Placebo (DRUG), Bonjesta (DRUG).
Who is sponsoring clinical trial NCT05289557?
This trial is sponsored by Duchesnay, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05289557 being conducted?
This trial has 10 study locations across California, Florida, Idaho, North Carolina, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.